BACKGROUND: Environmental enrichment has been shown to improve symptoms and reduce neuropathology in mouse models of Huntington's disease (HD); however results are limited to ex vivo techniques with associated shortcomings. In-vivo magnetic resonance imaging (MRI) can overcome some of the shortcomings and is applied for the first time here to assess the effect of a cognitive intervention in a mouse model of HD. OBJECTIVES: We aimed to investigate whether in-vivo high-field MRI can detect a disease-modifying effect in tissue macrostructure following a cognitive enrichment regime. METHODS: YAC128 transgenic and wild type mice were exposed to cognitive enrichment throughout their lifetime. At 20-months old, mice were scanned with a T2-weighted MRI sequence and a region-of-interest (ROI) approach was used to examine structural changes. Locomotor activity and performance on the rotarod and serial discrimination watermaze task were assessed to measure motor and cognitive function respectively. RESULTS: Mice exposed to cognitive enrichment were more active and able to stay on a rotating rod longer compared to control mice, with comparable rotarod performance between HD enriched mice and wild-type mice. YAC128 mice demonstrated cognitive impairments which were not improved by cognitive enrichment. In-vivo MRI revealed a reduction in the degree of caudate-putamen atrophy in the enriched HD mice. CONCLUSIONS: We provide in vivo evidence of a beneficial effect of environmental enrichment on neuropathology and motor function in a HD mouse model. This demonstrates the efficacy of MRI in a model of HD and provides the basis for an in-vivo non-destructive outcome measure necessary for longitudinal study designs to understand the effect of enrichment with disease progression.
BACKGROUND: Environmental enrichment has been shown to improve symptoms and reduce neuropathology in mouse models of Huntington's disease (HD); however results are limited to ex vivo techniques with associated shortcomings. In-vivo magnetic resonance imaging (MRI) can overcome some of the shortcomings and is applied for the first time here to assess the effect of a cognitive intervention in a mouse model of HD. OBJECTIVES: We aimed to investigate whether in-vivo high-field MRI can detect a disease-modifying effect in tissue macrostructure following a cognitive enrichment regime. METHODS: YAC128 transgenic and wild type mice were exposed to cognitive enrichment throughout their lifetime. At 20-months old, mice were scanned with a T2-weighted MRI sequence and a region-of-interest (ROI) approach was used to examine structural changes. Locomotor activity and performance on the rotarod and serial discrimination watermaze task were assessed to measure motor and cognitive function respectively. RESULTS: Mice exposed to cognitive enrichment were more active and able to stay on a rotating rod longer compared to control mice, with comparable rotarod performance between HD enriched mice and wild-type mice. YAC128 mice demonstrated cognitive impairments which were not improved by cognitive enrichment. In-vivo MRI revealed a reduction in the degree of caudate-putamen atrophy in the enriched HD mice. CONCLUSIONS: We provide in vivo evidence of a beneficial effect of environmental enrichment on neuropathology and motor function in a HD mouse model. This demonstrates the efficacy of MRI in a model of HD and provides the basis for an in-vivo non-destructive outcome measure necessary for longitudinal study designs to understand the effect of enrichment with disease progression.
Entities:
Keywords:
Huntington’s Disease; cognitive enrichment; magnetic resonance imaging; mouse model
Authors: Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano Journal: Neuroimage Date: 2002-09 Impact factor: 6.556
Authors: Jane S Paulsen; Peggy C Nopoulos; Elizabeth Aylward; Christopher A Ross; Hans Johnson; Vincent A Magnotta; Andrew Juhl; Ronald K Pierson; James Mills; Douglas Langbehn; Martha Nance Journal: Brain Res Bull Date: 2010-04-10 Impact factor: 4.077
Authors: Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; Hans J Johnson; Vincent A Magnotta; Andrew R Juhl; Ronald K Pierson; James Mills; Douglas R Langbehn; Jane S Paulsen Journal: Neurobiol Dis Date: 2010-08-02 Impact factor: 5.996
Authors: Jeffrey B Carroll; Jason P Lerch; Sonia Franciosi; Amanda Spreeuw; Nagat Bissada; R Mark Henkelman; Michael R Hayden Journal: Neurobiol Dis Date: 2011-03-31 Impact factor: 5.996
Authors: Sarah Biedermann; Johannes Fuss; Lei Zheng; Alexander Sartorius; Claudia Falfán-Melgoza; Traute Demirakca; Peter Gass; Gabriele Ende; Wolfgang Weber-Fahr Journal: Neuroimage Date: 2012-04-12 Impact factor: 6.556
Authors: Tara L Spires; Helen E Grote; Neelash K Varshney; Patricia M Cordery; Anton van Dellen; Colin Blakemore; Anthony J Hannan Journal: J Neurosci Date: 2004-03-03 Impact factor: 6.167
Authors: Elizabeth J Slow; Jeremy van Raamsdonk; Daniel Rogers; Sarah H Coleman; Rona K Graham; Yu Deng; Rosemary Oh; Nagat Bissada; Sazzad M Hossain; Yu-Zhou Yang; Xiao-Jiang Li; Elizabeth M Simpson; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden Journal: Hum Mol Genet Date: 2003-07-01 Impact factor: 6.150
Authors: Ivan Rattray; Edward Smith; Richard Gale; Kaoru Matsumoto; Gillian P Bates; Michel Modo Journal: PLoS One Date: 2013-04-04 Impact factor: 3.240
Authors: Jessica J Steventon; Rebecca C Trueman; Da Ma; Emma Yhnell; Zubeyde Bayram-Weston; Marc Modat; Jorge Cardoso; Sebastian Ourselin; Mark Lythgoe; Andrew Stewart; Anne E Rosser; Derek K Jones Journal: Sci Rep Date: 2016-09-01 Impact factor: 4.379